JOSÉ ÁNGEL
GARCÍA SÁENZ
Profesor asociado de Ciencias de la Salud
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari Germans Trias i Pujol (7)
2023
-
Correction to: SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2665-2678), 10.1007/s12094-023-03203-8)
Clinical and Translational Oncology
-
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2665-2678
2021
2015
-
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer:The Letrozole/Fulvestrant and Avastin (LEA) study
Journal of Clinical Oncology
-
SEOM clinical guidelines in early-stage breast cancer 2015
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 939-945
2011
-
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: Efficacy and cardiac safety from the GEICAM/2004-05 study
Annals of Oncology, Vol. 22, Núm. 12, pp. 2591-2596
2010
-
Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study
Breast Cancer Research and Treatment, Vol. 122, Núm. 1, pp. 169-176